Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse

被引:55
作者
Berman, S. M. [1 ,2 ]
Voytek, B. [1 ]
Mandelkern, M. A. [3 ]
Hassid, B. D. [1 ]
Isaacson, A. [1 ]
Monterosso, J. [1 ]
Miotto, K. [1 ]
Ling, W. [1 ]
London, E. D. [1 ,2 ,4 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90024 USA
[3] Univ Calif Irvine, Dept Phys, Irvine, CA 92717 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA
关键词
methamphetamine; drug abuse; brain metabolism; PET imaging; continuous performance test; abstinence;
D O I
10.1038/sj.mp.4002107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Changes in brain function during the initial weeks of abstinence from chronic methamphetamine abuse may substantially affect clinical outcome, but are not well understood. We used positron emission tomography with [F-18] fluorodeoxyglucose (FDG) to quantify regional cerebral glucose metabolism, an index of brain function, during performance of a vigilance task. A total of 10 methamphetamine-dependent subjects were tested after 5-9 days of abstinence, and after 4 additional weeks of supervised abstinence. A total of 12 healthy control subjects were tested at corresponding times. Global glucose metabolism increased between tests (P = 0.01), more in methamphetamine-dependent (10.9%, P = 0.02) than control subjects (1.9%, NS). Glucose metabolism did not change in subcortical regions of methamphetamine-dependent subjects, but increased in neocortex, with maximal increase (> 20%) in parietal regions. Changes in reaction time and self-reports of negative affect varied more in methamphetamine-dependent than in control subjects, and correlated both with the increase in parietal glucose metabolism, and decrease in relative activity (after scaling to the global mean) in some regions. A robust relationship between change in self-reports of depressive symptoms and relative activity in the ventral striatum may have great relevance to treatment success because of the role of this region in drug abuse-related behaviors. Shifts in cortical subcortical metabolic balance either reflect new processes that occur during early abstinence, or the unmasking of effects of chronic methamphetamine abuse that are obscured by suppression of cortical glucose metabolism that continues for at least 5-9 days after cessation of methamphetamine self-administration.
引用
收藏
页码:897 / 908
页数:12
相关论文
共 49 条
[1]  
BECK AT, 1987, MANUAL REV BECK DEPR
[2]   NITRIC-OXIDE REGULATION OF METHAMPHETAMINE-INDUCED DOPAMINE RELEASE IN CAUDATE-PUTAMEN [J].
BOWYER, JF ;
CLAUSING, P ;
GOUGH, B ;
SLIKKER, W ;
HOLSON, RR .
BRAIN RESEARCH, 1995, 699 (01) :62-70
[3]   Predictors of relapse after treatment for methamphetamine use [J].
Brecht, ML ;
von Mayrhauser, C ;
Anglin, MD .
JOURNAL OF PSYCHOACTIVE DRUGS, 2000, 32 (02) :211-220
[4]   The James-Lange theory of emotions: A critical examination and an alternative theory [J].
Cannon, WB .
AMERICAN JOURNAL OF PSYCHOLOGY, 1927, 39 :106-124
[5]  
DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773
[6]   Neuroplasticity: Changes in grey matter induced by training - Newly honed juggling skills show up as a transient feature on a brain-imaging scan [J].
Draganski, B ;
Gaser, C ;
Busch, V ;
Schuierer, G ;
Bogdahn, U ;
May, A .
NATURE, 2004, 427 (6972) :311-312
[7]   Evidence for long-term neurotoxicity associated with methamphetamine abuse -: A 1H MRS study [J].
Ernst, T ;
Chang, L ;
Leonido-Yee, M ;
Speck, O .
NEUROLOGY, 2000, 54 (06) :1344-1349
[8]  
First M, 2017, Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD)
[9]   THE EFFECT OF DIAZEPAM SEDATION ON CEREBRAL GLUCOSE-METABOLISM IN ALZHEIMERS-DISEASE AS MEASURED USING POSITRON EMISSION TOMOGRAPHY [J].
FOSTER, NL ;
VANDERSPEK, AFL ;
ALDRICH, MS ;
BERENT, S ;
HICHWA, RH ;
SACKELLARES, JC ;
GILMAN, S ;
AGRANOFF, BW .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1987, 7 (04) :415-420
[10]   Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers -: A double-blind, placebo-controlled PET study with [18F]FDG [J].
Gouzoulis-Mayfrank, E ;
Schreckenberger, M ;
Sabri, O ;
Arning, C ;
Thelen, B ;
Spitzer, M ;
Kovar, KA ;
Hermle, L ;
Büll, U ;
Sass, H .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (06) :565-581